Essential medicines for pediatric oncology in developing countries.
Pediatr Blood Cancer
; 60(5): 889-91, 2013 May.
Article
em En
| MEDLINE
| ID: mdl-23450774
ABSTRACT
The burden of cancer in children in low and middle income countries (LMICs) is substantial, comprising at least 80% of incident cases globally, and an even higher proportion of cancer-related deaths. With survival rates exceeding 80% in high income countries, it is imperative to transfer these successes to LMICs. A major challenge is the poor availability of safe, cost-effective chemotherapy. A list of 51 drugs-chemotherapeutics, infectious disease agents, and supportive care medications-is proposed as essential to improving the survival of children with cancer in LMICs with an additional 13 drugs identified as being of further value.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Medicamentos Essenciais
/
Países em Desenvolvimento
/
Acessibilidade aos Serviços de Saúde
/
Neoplasias
/
Antineoplásicos
Limite:
Child
/
Humans
Idioma:
En
Ano de publicação:
2013
Tipo de documento:
Article